Max Healthcare Institute working capital

Profitability Growth Credit Liquidity Working capital Dividend yield DuPont CAGR

Per cent unless marked ×

Tap a line for its trend	Last 12Mto Sep 2026	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

22.48×	22.48×	22.99×	25.46×	27.23×	FY22 and earlierEvery year the company has filed comes with Alpha Plus.
36.12×	36.12×	29.86×	26.97×	28.86×
169.95×	169.95×	183.53×	199.21×	215.14×
−111.35×	−111.35×	−130.68×	−146.78×	−159.05×
−23.07×	−34.58×	−31.77×	11.82×	5.08×
0.52×	0.52×	0.52×	0.49×	0.47×
1.13×	1.13×	1.36×	1.06×	1.10×
0.73×	0.73×	0.79×	0.75×	0.97×

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

MAXHEALTH₹851.15

Max Healthcare Institute Ltd.

· Pharma & Health

₹ CrorePeersAPOLLOHOSP FORTIS MEDANTA DRREDDY CIPLA SUNPHARMA DIVISLAB TORNTPHARMMcap ₹82,828 Cr

Profitability Growth Credit Liquidity Working Capital Yield Analysis DuPont

Ratios — % unless marked × 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/09/2026
Inventory Days (DIO)	27.23	25.46	22.99	22.48	22.48
Receivable Days (DSO)	28.86	26.97	29.86	36.12	36.12
Payable Days (DPO)	215.14	199.21	183.53	169.95	169.95
Cash Conversion Cycle (days)	-159.05	-146.78	-130.68	-111.35	-111.35
Working Capital Turnover	5.08	11.82	-31.77	-34.58	-23.07
Asset Turnover	0.47	0.49	0.52	0.52	0.52
Cash Conversion (CFO/Net Income)	1.10	1.06	1.36	1.13	1.13
CFO/EBITDA	0.97	0.75	0.79	0.73	0.73

No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 146%.